This medication is a low molecular weight heparin, prescribed for venous thromboembolism, pulmonary embolism and unstable angina.
Contraindicated in patients with history of abnormal decrease in platelet counts, uncontrolled high blood pressure, increased risk of bleeding, peptic ulceration, head injuries, stroke. It should not be administered by the IM route.
Adults: The dose is based on body weight. It is usually 86 anti-factor Xa International Units (IU) per kilogram (kg) (39.1 anti-factor Xa IU per pound) of body weight injected under the skin every twelve hours for six days.
Venous thromboembolism and Pulmonary Embolism:
Adults: The dose is usually 2850 anti-factor Xa IU injected under the skin once a day beginning two to four hours before surgery and continuing for at least seven days.
It comes as a solution for injection, to be administered by a healthcare provider under the skin.
• Caution should be exercised in patients undergoing epidural anesthesia, history of heparin-induced platelet defects, increased risk of bleeding, severe liver or kidney disease, any allergy, during pregnancy and breastfeeding.
• Monitor signs of bleeding and potassium level in blood.
• Most Common:
Injection site blood clot, bruising, pain at injection site, decrease in platelets, nosebleed and blood in urine/stool.
Avoid excess dosage.
Store it at controlled room temperature (15-30°C). Do not freeze or refrigerate.
Subscribe to our Free Newsletters!